Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study

Table 7

Bilirubin levels of the two groups.

	C-117 formula group (n=59)	Placebo group (n=59)	Z/T	P
Total bilirubin (umol/L)
Before treatment	10.74 ± 5.58	9.30 ± 2.64
After treatment	11.08 ± 4.17	9.60 ± 2.32	-1.639	0.101
Direct bilirubin (umol/L)
Before treatment	3.54 ± 1.56	3.20 ± 0.87
After treatment	3.90 ± 1.24	3.54 ± 0.84	-1.561	0.119
Indirect bilirubin (umol/L)
Before treatment	7.16 ± 4.17	6.06 ± 1.87
After treatment	7.16 ± 3.10	6.06 ± 1.79	-1.587	0.112

M, mean ± standard deviation. P is the P value of the FAS dataset;
P<0.05 vs. before treatment.